title: Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.
authors.affiliation: Programa de Pós-Graduação em Medicina e Saúde (PPgMS), Faculdade de Medicina da Bahia, Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil.
authors.forename: Paulo Adriano
authors.initials: PA
authors.lastname: Schwingel
authors.forename: Helma P
authors.initials: HP
authors.lastname: Cotrim
authors.forename: Bernardo Rios
authors.initials: BR
authors.lastname: Salles
authors.forename: Carlos Eduardo
authors.initials: CE
authors.lastname: Almeida
authors.forename: Crimério Ribeiro
authors.initials: CR
authors.lastname: dos Santos
authors.forename: Bruno
authors.initials: B
authors.lastname: Nachef
authors.forename: Antonio Ricardo
authors.initials: AR
authors.lastname: Andrade
authors.forename: Cláudio C
authors.initials: CC
authors.lastname: Zoppi
mesh_terms: D000328:Adult; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects*; D001938:Brazil / Q000453:epidemiology; D016022:Case-Control Studies; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D005234:Fatty Liver / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D007273:Injections, Intramuscular; D007333:Insulin Resistance / Q000502:physiology; D008099:Liver / Q000187:drug effects*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease; D058573:Performance-Enhancing Substances / Q000009:adverse effects*; D013177:Sports; D019966:Substance-Related Disorders / Q000453:epidemiology / Q000209:etiology; D000637:Transaminases / Q000097:blood; D055815:Young Adult
chemical_list: D045930:Anabolic Agents; D000728:Androgens; D058573:Performance-Enhancing Substances; D000637:Transaminases